Abstract:Abstract Background Colorectal surgery in patients with inflammatory bowel disease (IBD) and cirrhosis is associated with high morbidity related to portal hypertension. Thought to reduce surgical risk, transjugular intrahepatic portosystemic shunt (TIPS) may be used to decrease portal pressures. In this study, we aimed to characterize surgical outcomes of patients with IBD and cirrhosis who underwent preoperative TIPS at a large tertiary care center. Methods We retrospectively identified patients with IBD and cirrhosis who had undergone TIPS between 2010-2023 for portal decompression prior to colorectal surgery. All other indications for TIPS led to patient exclusion. Demographic and medical data was collected, including surgical indication and portal pressure measurement. Data on surgical outcomes were compiled through chart review. Results We identified 10 patients (60% male) with IBD and history of decompensated cirrhosis who underwent preoperative TIPS for portal decompression (Table 1). Surgical indications were colonic dysplasia (50%), refractory IBD (50%), and stenosis or stricture (30%). All patients were deemed nonsurgical candidates due to significant surgical risk from portal hypertension. Following multidisciplinary coordination, patients underwent TIPS for portal decompression at a median of 47 days (IQR 34-80) prior to colorectal surgery. TIPS was associated with significant reduction in portal pressure (22.5 vs 18.5mmHg, p<0.01) and portosystemic gradient (12.5 vs 5.5mmHg, p<0.01) in all patients. Of 10 patients, 30% had TIPS-related complications (transient fluid overload and encephalopathy). In terms of surgical complications, 40% of patients required intraoperative blood transfusion (range: 1-4 units). Postoperatively, 30% of patients had surgical site bleeding and 10% had wound dehiscence, although none required reoperation. Systemic complications occurred in 30% of patients, with systemic signs of infection being the most common. Transaminitis (50%) and coagulopathy (40%) were also common. Median hospital stay was 7 days (IQR 5.5-9.3), with 40% of patients being readmitted within 30 days. Most common cause of readmission was systemic infection (75%), abdominal abscess (50%), or electrolyte abnormality (50%), with one patient requiring reoperation for wound dehiscence. Ninety-day and 1-year survival was 100% and 90% respectively. Conclusion In our series of patients with IBD and cirrhosis requiring surgery but deemed nonsurgical candidates, preoperative TIPS lead to portal decompression and facilitated successful surgical intervention despite heightened risk. Nevertheless, significant operative and postoperative complications were noted. Future studies are needed to determine optimal surgical timing following TIPS placement.

Simultaneous total internal biliary diversion during liver transplantation for progressive familial intrahepatic cholestasis Type 1: Standard of care?

A Report of 2 Infant Siblings with Progressive Intrahepatic Familial Cholestasis Type 1 and a Novel Homozygous Mutation in the ATP8B1 Gene Treated with Partial External Biliary Diversion and Liver Transplant

Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series

Biliary Drainage after Laparoscopic Choledochotomy

Long-Term Results of Pediatric Liver Transplantation for Progressive Familial Intrahepatic Cholestasis

Clinical analysis of liver transplantation in progressive familial intrahepatic cholestasis

Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients.

Management of Biliary Stricture in Pediatric Living Donor Liver Transplantation Recipients

Living Donor Liver Transplantation in Treating Progressive Familiar Intrahepatic Cholestasis in Children

Liver Transplantation for Decompensated Liver Cirrhosis Caused by Progressive Familial Intrahepatic Cholestasis Type 3: A Case Report.

Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency.

Percutaneous transhepafic cholangiography and drainage for treatment of biliary complications after liver transplantation

Simultaneous Pancreaticoduodenectomy and Liver Transplantation for Biliary Atresia Complicated by Choledochal Cyst

Treatment of intractable cholangitis in children with biliary atresia: Impact on outcome

Long-term outcome of combined radiologic and surgical strategy for the management of biliary complications after pediatric liver transplantation

P1059 Use of preoperative transjugular intrahepatic portosystemic shunt (TIPS) in patients with Inflammatory Bowel Disease and cirrhosis

Animal Experimental Study of Percutaneous Transhepatic Cholangiogastric Drainage for the Management of Biliary Tract Obstruction

The Influence of Transjugular Intrahepatic Portosystemic Shunt with Concurrent Left Gastric Vein Embolization on the Liver Function of Patients with Liver Cirrhosis

Postsurgical Management of Dilated Biliary Tract in Children: Ultrasound-Guided Percutaneous Transhepatic Cholangial Drainage and Subsequent Percutaneous Ultrasound Cholangiography

Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention

Treatments and outcomes of intra-operative portal vein thrombosis in living-donor liver transplantation due to biliary atresia